Evaluate Safety, Tolerability, PK, Preliminary Clinical Activity of OB318 in Patients With Advanced Solid Malignancies
Clinical trial NCT02347228 · TERMINATED
Trial details
- NCT number
- NCT02347228
- Sponsor
- Oneness Biotech Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-28
- Primary completion
- 2024-11-22
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.